Cognitive Impairment and Balance in Elderly
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02051270|
Recruitment Status : Completed
First Posted : January 31, 2014
Last Update Posted : November 2, 2016
|Condition or disease||Intervention/treatment|
|Mild Cognitive Impairment||Other: Descriptive study|
|Study Type :||Observational|
|Actual Enrollment :||82 participants|
|Official Title:||Mild Cognitive Impairment and Balance in Elderly|
|Study Start Date :||January 2014|
|Actual Primary Completion Date :||April 2015|
|Actual Study Completion Date :||May 2015|
Older people living in nursing homes will undergo a descriptive study.
Other: Descriptive study
More than 65 years old elders
- Dynamic balance [ Time Frame: baseline ]Dynamic balance is going to be measured using the Mini-Best test. This is a 14-item test that focuses on dynamic balance, specifically anticipatory transitions, postural responses, sensory orientation, and dynamic gait
- Cognitive impairment [ Time Frame: baseline ]The cognitive impairment will be measured using the Montreal Cognitive Assessment and the Mini-Mental State Examination. The Montreal Cognitive Assessment is a test designed as a rapid screening instrument for mild cognitive dysfunction. It assesses different cognitive domains: attention and concentration, executive functions, memory, language, visuoconstructional skills, conceptual thinking, calculations, and orientation. The Mini Mental State Examination is a 10-minute bedside measure of impaired thinking in undeveloped, uneducated, diseased, or very old populations.
- Attention [ Time Frame: baseline ]Attention is going to be measured with the Stroop test.
- Cognitive flexibility [ Time Frame: baseline ]The cognitive flexibility of patients is measured using the Trial Making Test. This test explores visual-conceptual and visual-motor tracking, and it is a frequently used neuropsychological test.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02051270
|Faculty of health Sciences. University of Granada|
|Granada, Spain, 18071|
|Principal Investigator:||Marie Carmen Valenza, PhD||Universidad de Granada|